Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest valuation. Its stock price is up 5.3% this year, compared with 16% growth for the S 500.

Why isn't Merck's stock doing better in 2024?

More importantly, could this healthcare company make for a good investment today?

Continue reading

Source Fool.com